The dynamic multi-media laboratory at the exhibit’s focal point will be named the Biogen Idec Foundation Exploration Hub. This is the largest single grant awarded by the Biogen Idec Foundation to any organization, the foundation said.
The hall “signals the beginning of a new era at the museum as we transform our halls to tell the story of the natural and engineered worlds,” Ioannis Miaoulis, museum president and director, said in a statement.
The foundation said the award was part of its ongoing efforts to support STEM initiatives, STEM standing for science, technology, engineering, and math.
“The Biogen Idec Foundation and the Museum of Science share a long-term commitment to bring innovative, accessible, and interactive STEM education to the Greater Boston community,” Tony Kingsley, chairman of the Biogen Idec Foundation, said in a statement.
Among the drugs that Biogen Idec markets are the multiple sclerosis pill Tecfidera and another MS drug called Tysabri. The company has about 6,800 employees worldwide, including 2,800 in Massachusetts, where it hired more than 400 workers last year.